Eledon Pharmaceuticals, Inc. · NASDAQ:ELDN
Eledon Pharmaceuticals, Inc. shareholders
As of Jun 30, 2026, 156 institutions reported holding Eledon Pharmaceuticals, Inc., 57.8% of its shares. Largest: Bvf Inc, BlackRock and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Eledon Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| Bvf Inc | 6.29M | 7.7% | no change | Aug 14, 2026 |
| BlackRock | 5.12M | 6.3% | +742K | Aug 7, 2026 |
| Vanguard | 4.5M | 5.5% | +255K | Aug 13, 2026 |
| Defilade Capital Management, L.P. | 3.53M | 4.3% | −38,789 | Aug 14, 2026 |
| Goldman Sachs | 2.51M | 3.1% | +2.14M | Aug 14, 2026 |
| Ensign Peak Advisors, Inc | 2.1M | 2.6% | −364K | Aug 14, 2026 |
| Geode Capital | 1.96M | 2.4% | +165K | Aug 12, 2026 |
| Catalio Capital Management, LP | 1.7M | 2.1% | +55,255 | Aug 14, 2026 |
| State Street | 1.62M | 2.0% | +467K | Aug 7, 2026 |
| Zimmer Partners, LP | 1.6M | 2.0% | −278K | Aug 14, 2026 |